Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azitromycin Use in COVID-19 Positive Pediatric Patients; Effect on Ventricle Repolarization

NCT04699097 is registered in ClinicalTrials.gov with Kayseri City Hospital as lead sponsor.

NCT NCT04699097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04699097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azitromycin Use in COVID-19 Positive Pediatric Patients; Effect on Ventricle Repolarization
Lead sponsor
Kayseri City Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2020
Completion date
November 1, 2020
Enrollment
105 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

azithromycin adverse reaction, covid19, long qt syndrome